Open, Non Comparative Study Of Voriconazole In Slovak Patients With Very High Risk Of Developing An Invasive Fungal Infection

Voriconazole In High-Risk Patients With Invasive Fungal Infections In Slovakia. An Open, Prospective, Non-Comparative Study

Assessment of safety and efficacy of voriconazole in real-life setting in the treatment of high risk patients with invasive fungal infections. The study is conducted in Slovakia only.

Inclusion Criteria:

• Male or female patient of age 2 years or older.
• High-risk patients with proven, probable or possible invasive fungal infection (IFI) according to the EORTC/MSG criteria.
• Patients indicated for secondary prophylaxis of invasive aspergillosis.

Exclusion Criteria:

• Patients with known hypersensitivity to voriconazole or to any of the excipients.
• Patients with contraindicated concomitant medications according to the SmPC.
• Children less than 2 years of age.
• Pregnancy and lactation.